Healthcare tech firm Mendaera announced that it has raised $73 million in series B financing.
The funding round was led by Threshold Ventures, with participation from Lux Capital, PFM Health Sciences, and Fred Moll (the founder of Intuitive Surgical and Auris Health).
In a statement, Mendaera said that the financing will further the development of its handheld robotic interventional platform, accelerate development of its artificial intelligence (AI) and connectivity capabilities, and enable the firm to begin the clinical introduction of its platform.
According to the San Mateo, CA-based Mendaera, the platform, which is designed for mainstream medical procedures, incorporates robotics, AI, real-time imaging, and virtual connectivity, and is accessible across multiple specialties and sites of service.
"Traditional surgical robots have established footing in the operating room," osh DeFonzo, founder and CEO of Mendaera, said. "But robotics and AI have evolved to a point where we can deliver broader benefits across all parts of the healthcare system and enable higher standards of care for more patients. We believe that our technology will allow healthcare systems and providers to provision medical procedures at scale -- enhancing patient experience, increasing access to high-quality care, reducing overall cost, and improving healthcare provider satisfaction."
Mendaera reached an agreement in December 2023 with point-of-care ultrasound company Butterfly Network to incorporate Butterfly’s ultrasound-on-chip technology into the platform. In March, Mendaera announced that it had added Avail Medsystems' telepresence technology to its portfolio.
